It is worth noting that the observed inhibitory Ser366 phosphorylation of eEF2K may limit cancer cell migration and metastasis [56], although an increased metastatic growth has been reported for a number of cancer types with the active ghrelin-GHSR axis [31]. This evidence concerns the gene EEF2K and cancer.